WO1989006986A1 - Y connector for angioplasty procedure - Google Patents

Y connector for angioplasty procedure Download PDF

Info

Publication number
WO1989006986A1
WO1989006986A1 PCT/US1988/003411 US8803411W WO8906986A1 WO 1989006986 A1 WO1989006986 A1 WO 1989006986A1 US 8803411 W US8803411 W US 8803411W WO 8906986 A1 WO8906986 A1 WO 8906986A1
Authority
WO
WIPO (PCT)
Prior art keywords
seal
spigot
passageway
catheter
connector
Prior art date
Application number
PCT/US1988/003411
Other languages
French (fr)
Inventor
William E. Patton
William J. Lindsey
Original Assignee
Medex, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medex, Inc. filed Critical Medex, Inc.
Publication of WO1989006986A1 publication Critical patent/WO1989006986A1/en
Priority to DK069090A priority Critical patent/DK69090D0/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00—Catheters; Hollow probes
    • A61M25/10—Balloon catheters
    • A61M25/104—Balloon catheters used for angioplasty
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M39/00—Tubes, tube connectors, tube couplings, valves, access sites or the like, specially adapted for medical use
    • A61M39/02—Access sites
    • A61M39/06—Haemostasis valves, i.e. gaskets sealing around a needle, catheter or the like, closing on removal thereof
    • A61M39/0613—Haemostasis valves, i.e. gaskets sealing around a needle, catheter or the like, closing on removal thereof with means for adjusting the seal opening or pressure

Definitions

  • This invention relates to a Y connector for use in an angioplasty procedure.
  • the angioplasty procedure for repair of a blood vessel has been known for many years.
  • the procedure provides an opportunity to open up a clogged blood vessel, particularly a coronary artery, and thus avoid the expense and trauma of bypass surgery.
  • a Y connector is attached to the free end of the guide catheter by means of a rotatable coupling of the type disclosed in U. S. Patent No. 4,254,773.
  • the Y connector has a main passage through which the dilatation catheter is inserted.
  • the Y connector has a branch passage to which a multiport manifold is connected.
  • One port of the manifold is connected to a blood pressure monitor of the type disclosed in copending application Serial No. 07/072,909, filed July 14, 1987.
  • Another port of the manifold is connected to a supply of contrast media which is a fluid injected into the blood vessel enabling a real time observation of the bloodvessel through X-ray.
  • the angioplasty procedure involves the following steps: The guide catheter is inserted through a blood vessel in the patient's arm or leg into the heart.
  • a blood pressure monitor is connected to the Y connector to provide a continuous monitor of a patient's blood pressure.
  • the contrast medium is introduced into the blood vessel so that the blockage of the blood vessel can be identified.
  • a dilatation catheter having a balloon on its free end is introduced through the main passage of the Y connector.
  • a saline mixture is injected through the dilatation catheter to the balloon on its end to inflate it.
  • T e dilatation catheter is thereafter removed and contrast medium again introduced and a post dilatation arteriogram is made to check the success of the procedure.
  • the dilatation catheter may be reintroduced. It may be desired to use a larger catheter. It may be desired to introduce a small guide wire instead of a dilatation catheter. In any event, more than one insertion and withdrawal through the main passageway is normally required to complete the angioplasty procedure.
  • Blood under normal body pressure is of course in the main passageway just as it is in the branch passageway where it is being continuously monitored.
  • the blood will tend to escape through the main passageway as by directly flowing through the main passageway when a catheter is removed or by flowing by the catheter when it has been inserted.
  • Tuohy Borst valve includes an O-ring-type element seated in a socket forming part of the main passage.
  • a cap threaded on the end of the passage contains a spigot which com ⁇ presses the O-ring when the cap is rotated to drive the spigot inwardly.
  • the compression closes down the opening in the O-ring around the catheter to prevent "flow-by.”
  • the O-ring can be closed down enough to completely close off the opening in the main passage.
  • An alternative form of seal employs a membrane having a small hole of about .045" diameter.
  • the Tuohy Borst has the disadvantage that it requires manipulation in order to match the size of the opening in the ring to the outside di- ameter of the dilatation catheter. If the cardiol ⁇ ogist does not tighten it sufficiently, blood will flow by the valve. If it is too tight, the catheter can be inserted only with difficulty because of the friction or the catheter can be crushed.
  • the membrane-type seal eliminates the foregoing disadvantages of the Tuohy Borst valve but has its own disadvantages. It cannot be completely closed off when a catheter is removed.
  • a Y connector having, in the main passage, a socket that receives a Tuohy Borst
  • a cap with a spigot projecting from it the cap being threaded onto the outside surface of the socket so that it can be screwed down to bring the spigot into contact with the Tuohy Borst ring to compress it.
  • the cap has sealed into it a membrane having a .040" to .035" diameter opening for receipt of a catheter.
  • the spigot and socket are provided with projecting and interfering collars or rims that limit the axial movement of the spigot out of the socket. The limitation is such that when the collars are touching, the spigot is in engagement with the Tuohy Borst ring to hold it in sufficient compression to block flow of blood around the external surface of the ring, that is, between the ring and the socket.
  • the combination as described permits or facilitates a number of procedures that have hereto ⁇ fore not been possible with any Y connector.
  • the dilatation catheter can be inserted through the membrane and no manipulation is required to effect the seal between the membrane and the catheter.
  • the catheter can be removed and blood flow through the main passage blocked by tightening down on the Tuohy Borst ring to close it completely.
  • the membrane-type seal is available without solvent-sealing of the membrane-containing cap to the connector, the external surface of the Tuohy Borst ring providing the seal against flow-by.
  • An undersized catheter or thin wire can be used even though its outside diameter would be smaller than the I.D. of the membrane, for in this situation, the Tuohy Borst valve could be tightened.
  • Fig. 1 is a diagrammatic view of the appara ⁇ tus for performing an angioplasty procedure
  • Fig. 2 is a cross-sectional view of the Y connector
  • Fig. 3 is an enlarged fragmentary view of the encircled portion of Fig. 2.
  • a guide catheter 10 is 15 inserted, via a patient's arm or leg 13, into the heart 14 adjacent the coronary artery.
  • a dilatation catheter 11 is positioned inside the bore of the guide catheter.
  • a balloon 12 which is inflatable by the injection of a - ⁇ - saline-based solution.
  • the guide catheter 10 has a hub 15 that is connected to a rotatable coupling 16 of the type disclosed in U. S. Patent No. 4,254,773.
  • a Y connec ⁇ tor 20 is formed by a clear plastic casing 19 that has 5 a standard male Luer slip 21 which is inserted into the end of the rotator coupling 16.
  • the Y connector has a main passage 22 and a branch passage 23.
  • the branch passage terminates in a standard female Luer lock 24.
  • a manifold 25 is connected by way of the Luer lock to the branch passage 23.
  • the manifold has at least two ports 26 and 27 that are controlled by stopcocks 28.
  • One port, 27, for example, is connected to a blood pressure monitor of the type described in patent application Serial No. 07/072,909, filed July 14, 1987.
  • the manifold has another port 30 which is connected to a supply of contrast medium that is to be inserted into the coronary artery to provide the contrast for an arteriogram that is used throughout the procedure.
  • the main branch 22 has a socket 35 which is threaded as at 36 on its external surface.
  • the socket has an internal surface 37 having a tapered valve seat 38 at one end.
  • a silicon or rubber O-ring 40 is seated at the bottom of the socket against the tapered seat 38.
  • the cross section of the O-ring 40 is trapezoidal.
  • One surface 41 of the trapezoid sits on the seat 38.
  • the other surface 42 of the trapezoid is engaged by a frustoconical surface 45 at the end of a spigot 46.
  • the O-ring has a circular opening which, in a relaxed condition, is about .080 inch.
  • the spigot 46 is integral with a skirt 47 that surrounds the socket 35 and has internal threads by which it is threaded onto the threads 36 of the socket.
  • the spigot and skirt form a closure 48.
  • the spigot has a bore 50 which is coaxial with the main passageway 22 and a bore 51 through the
  • the 50 is a membrane 55 having a tiny bore 56 of .040" to .035" diameter which grips the catheter 11 and forms a seal with it.
  • the membrane 55 is retained on the closure 48 by means of a cap 57 that is ultrasonically welded to the spigot assembly to form a leak-tight seal with the spigot assembly.
  • the socket 35 has an inwardly-directed collar 60 and the spigot 46 has an outwardly-directed collar or rim 61.
  • the collar 61 is in engagement with the collar 60, thus defining the outer limit of movement of the spigot with respect to the socket.
  • the seal against flow-by will always be maintained by the compression of the ring 40 against the seat 38 and the surface 42.
  • the dilatation catheter 11 passes through the main passageway 22, the bore 51 in the O-ring, the bore 50 in the spigot, the bore 56 in the membrane and out of the proximal end of the Y connector.
  • the free end of the dilatation catheter is connected to a supply of a saline mixture by which the balloon 12 in the dilatation catheter is inflated.
  • the guide catheter is connect ⁇ ed to the Y connector and the manifold with its attachments are attached to the Y connector.
  • the guide catheter is inserted via the patient's arm or leg into the patient's coronary artery. As it is snaked through that tortuous path, the rotator 16 permits it to twist while the Y connector and its attachments remain in a relatively fixed position.
  • the contrast medium With the guide catheter in place, the contrast medium is inserted through the port 30 and the branch passageway 23. With the contrast medium in the coronary artery, an arteriogram shows the cardi ⁇ ologist the area of blockage.
  • the dilatation catheter is then inserted into the coronary artery with the balloon 12 posi ⁇ tioned within the area of blockage. Possibly prelimi ⁇ nary to the insertion of the dilatation catheter, a small guide wire will have to be inserted in order to open the blocked artery sufficiently to permit the introduction of the balloon catheter.
  • a small guide wire will have to be inserted in order to open the blocked artery sufficiently to permit the introduction of the balloon catheter.
  • the dilata ⁇ tion catheter passes through the membrane 55, it is sealed with respect to the membrane and blood is prevented from exiting the Y connector via the membrane. Blood is also prevented from flowing between the spigot and socket surfaces by the slight compression of the O-ring 40 against the seat 38 and the frustoconical surface 45 on the spigot.
  • the seal against flow-by at the rubber seal 40 will remain intact.
  • the dilatation catheter Once the dilatation catheter is in place, it is gradually inflated to rupture the placque that is creating the blockage of the coronary artery. The catheter is thereafter withdrawn. When it is with ⁇ drawn, blood will want to exit through the membrane 50. However, by turning down the spigot onto the Tuohy Borst valve, the valve can be completely closed down, thereby blocking flow of blood out of the main passage 22.
  • contrast medium is again injected and an arteriogram is viewed to determine the success of the procedure thus far. It may be determined that a larger dilata ⁇ tion catheter should be inserted. If so, that opera ⁇ tion is performed by partially inserting the catheter up to the Tuohy Borst valve, opening the Tuohy Borst valve and proceeding with the insertion of the cathe- ter. The inflation procedure is repeated.
  • the leakage can be blocked by the turning down of the Tuohy Borst valve, care being exercised to prevent the crushing of the small catheter or impart ⁇ ing such a great friction to it or the wire that it cannot be threaded into the artery.

Abstract

The connector (20) has a main passage (23) through which a dilatation catheter (11) passes. Combined Tuohy-Borst valve (40) and membrane seals (55) are provided in the main passage to seal the catheter (11) against flow-by.

Description

Y Connector for Angioplasty Procedure Background of the Invention
This invention relates to a Y connector for use in an angioplasty procedure.
The angioplasty procedure for repair of a blood vessel has been known for many years. The procedure provides an opportunity to open up a clogged blood vessel, particularly a coronary artery, and thus avoid the expense and trauma of bypass surgery.
The procedure involves the insertion of a large guide catheter up to the blood vessel to be repaired. A Y connector is attached to the free end of the guide catheter by means of a rotatable coupling of the type disclosed in U. S. Patent No. 4,254,773. The Y connector has a main passage through which the dilatation catheter is inserted. The Y connector has a branch passage to which a multiport manifold is connected. One port of the manifold is connected to a blood pressure monitor of the type disclosed in copending application Serial No. 07/072,909, filed July 14, 1987. Another port of the manifold is connected to a supply of contrast media which is a fluid injected into the blood vessel enabling a real time observation of the bloodvessel through X-ray.
At a minimum, the angioplasty procedure involves the following steps: The guide catheter is inserted through a blood vessel in the patient's arm or leg into the heart.
A blood pressure monitor is connected to the Y connector to provide a continuous monitor of a patient's blood pressure.
The contrast medium is introduced into the blood vessel so that the blockage of the blood vessel can be identified. A dilatation catheter having a balloon on its free end is introduced through the main passage of the Y connector. When the end of the dilatation catheter is in place in the area of the blockage caused by a growth of placque, a saline mixture is injected through the dilatation catheter to the balloon on its end to inflate it. As the balloon is inflated, it ruptures the placque in the coronary artery so as to permit normal or at least improved blood flow. T e dilatation catheter is thereafter removed and contrast medium again introduced and a post dilatation arteriogram is made to check the success of the procedure.
Thereafter, the dilatation catheter may be reintroduced. It may be desired to use a larger catheter. It may be desired to introduce a small guide wire instead of a dilatation catheter. In any event, more than one insertion and withdrawal through the main passageway is normally required to complete the angioplasty procedure.
Blood under normal body pressure is of course in the main passageway just as it is in the branch passageway where it is being continuously monitored. The blood will tend to escape through the main passageway as by directly flowing through the main passageway when a catheter is removed or by flowing by the catheter when it has been inserted.
It is known in the prior art to provide sealing against the escape of blood through the main passageway of the Y connector. One seal is an adjust¬ able Tuohy Borst type valve. The Tuohy Borst valve includes an O-ring-type element seated in a socket forming part of the main passage. A cap threaded on the end of the passage contains a spigot which com¬ presses the O-ring when the cap is rotated to drive the spigot inwardly. The compression closes down the opening in the O-ring around the catheter to prevent "flow-by." When the catheter is absent, the O-ring can be closed down enough to completely close off the opening in the main passage.
An alternative form of seal employs a membrane having a small hole of about .045" diameter.
Catheters of a slightly larger outside diameter than the hole are inserted through the membrane, the membrane forming the seal against "flow-by." Neither Y connector seal is completely satisfactory. The Tuohy Borst has the disadvantage that it requires manipulation in order to match the size of the opening in the ring to the outside di- ameter of the dilatation catheter. If the cardiol¬ ogist does not tighten it sufficiently, blood will flow by the valve. If it is too tight, the catheter can be inserted only with difficulty because of the friction or the catheter can be crushed. The membrane-type seal eliminates the foregoing disadvantages of the Tuohy Borst valve but has its own disadvantages. It cannot be completely closed off when a catheter is removed. Under those circumstances, when the dilatation catheter is remov- ed, the Y connector has to be removed and the mani¬ fold connected directly to the rotator. During this step, there is nothing to prevent the blood from flowing through the guide catheter and into the surgical area. Further, the smaller catheters, for example .036" O.D. , cannot properly be sealed by a membrane that has a hole that is .045" diameter. Brief Summary of the Invention
It is an objective of the invention to provide an improved seal for the Y connector, the improved seal eliminating the disadvantages of the Tuohy Borst and membrane-type seals of the prior art.
More specifically, it is an objective of the invention to provide a seal which permits insertion of the dilatation catheter without need for manipulation of the connector to effect the seal and which pre¬ cludes blood flow-by; and which permits all steps of the procedure to be performed without requiring the disconnection of the Y connector.
The objects of the present invention are attained by providing a Y connector having, in the main passage, a socket that receives a Tuohy Borst
O-ring, a cap with a spigot projecting from it, the cap being threaded onto the outside surface of the socket so that it can be screwed down to bring the spigot into contact with the Tuohy Borst ring to compress it. The cap has sealed into it a membrane having a .040" to .035" diameter opening for receipt of a catheter. The spigot and socket are provided with projecting and interfering collars or rims that limit the axial movement of the spigot out of the socket. The limitation is such that when the collars are touching, the spigot is in engagement with the Tuohy Borst ring to hold it in sufficient compression to block flow of blood around the external surface of the ring, that is, between the ring and the socket.
This relationship is important to maintain a seal against flow-by when the membrane is used for the seal. In the prior art, the cap containing the membrane is solvent-sealed to the connector. Such a seal is ruled out when it is necessary to have the threaded connection for a Tuohy-Borst-type operation. Therefore, the combination provides a seal for the membrane-type procedure that does not require the solvent sealing.
The combination as described permits or facilitates a number of procedures that have hereto¬ fore not been possible with any Y connector. The dilatation catheter can be inserted through the membrane and no manipulation is required to effect the seal between the membrane and the catheter. The catheter can be removed and blood flow through the main passage blocked by tightening down on the Tuohy Borst ring to close it completely. The membrane-type seal is available without solvent-sealing of the membrane-containing cap to the connector, the external surface of the Tuohy Borst ring providing the seal against flow-by. An undersized catheter or thin wire can be used even though its outside diameter would be smaller than the I.D. of the membrane, for in this situation, the Tuohy Borst valve could be tightened. Thus, the full range of catheters and guide wires is available with the single connector. There never would be a requirement for removal of the connector and reconnecting the manifold to the guide catheter as is the case with some procedures using the membrane. The need for a precise sealing adjustment as is required in the Tuohy Borst valve is eliminated for all but the smallest catheters. The possibility of air embolism that can occur when the connector is removed and the manifold attached to the guide cathe¬ ter and vice versa is eliminated.
All of the foregoing objects, features and advantages of the invention will become more readily
5 apparent from the following detailed description taken in conjunction with the accompanying drawings in which:
Fig. 1 is a diagrammatic view of the appara¬ tus for performing an angioplasty procedure; 10 Fig. 2 is a cross-sectional view of the Y connector; and
Fig. 3 is an enlarged fragmentary view of the encircled portion of Fig. 2.
Referring to Fig. 1, a guide catheter 10 is 15 inserted, via a patient's arm or leg 13, into the heart 14 adjacent the coronary artery. A dilatation catheter 11 is positioned inside the bore of the guide catheter. At the end of the dilatation catheter is a balloon 12 which is inflatable by the injection of a -■ - saline-based solution.
The guide catheter 10 has a hub 15 that is connected to a rotatable coupling 16 of the type disclosed in U. S. Patent No. 4,254,773. A Y connec¬ tor 20 is formed by a clear plastic casing 19 that has 5 a standard male Luer slip 21 which is inserted into the end of the rotator coupling 16.
The Y connector has a main passage 22 and a branch passage 23. The branch passage terminates in a standard female Luer lock 24. A manifold 25 is connected by way of the Luer lock to the branch passage 23. The manifold has at least two ports 26 and 27 that are controlled by stopcocks 28. One port, 27, for example, is connected to a blood pressure monitor of the type described in patent application Serial No. 07/072,909, filed July 14, 1987. The manifold has another port 30 which is connected to a supply of contrast medium that is to be inserted into the coronary artery to provide the contrast for an arteriogram that is used throughout the procedure.
The main branch 22 has a socket 35 which is threaded as at 36 on its external surface. As seen in Fig. 3, the socket has an internal surface 37 having a tapered valve seat 38 at one end. A silicon or rubber O-ring 40 is seated at the bottom of the socket against the tapered seat 38. The cross section of the O-ring 40 is trapezoidal. One surface 41 of the trapezoid sits on the seat 38. The other surface 42 of the trapezoid is engaged by a frustoconical surface 45 at the end of a spigot 46. The O-ring has a circular opening which, in a relaxed condition, is about .080 inch.
The spigot 46 is integral with a skirt 47 that surrounds the socket 35 and has internal threads by which it is threaded onto the threads 36 of the socket. The spigot and skirt form a closure 48. By rotating the spigot assembly on the socket, the spigot
46 will move axially toward and away from the flexible
O-ring 40 to compress it or relieve the pressure against the seat 38, thus creating a Tuohy Borst-type valve.
The spigot has a bore 50 which is coaxial with the main passageway 22 and a bore 51 through the
O-ring 40. At the outer or proximal end of that bore
50 is a membrane 55 having a tiny bore 56 of .040" to .035" diameter which grips the catheter 11 and forms a seal with it. The membrane 55 is retained on the closure 48 by means of a cap 57 that is ultrasonically welded to the spigot assembly to form a leak-tight seal with the spigot assembly. The socket 35 has an inwardly-directed collar 60 and the spigot 46 has an outwardly-directed collar or rim 61. When the spigot 46 is inserted into the socket far enough to slightly compress the soft ring 40 on the seat 38, the collar 61 is in engagement with the collar 60, thus defining the outer limit of movement of the spigot with respect to the socket. As long as the spigot goes no farther outward with respect to the socket, the seal against flow-by will always be maintained by the compression of the ring 40 against the seat 38 and the surface 42.
During a procedure, the dilatation catheter 11 passes through the main passageway 22, the bore 51 in the O-ring, the bore 50 in the spigot, the bore 56 in the membrane and out of the proximal end of the Y connector. The free end of the dilatation catheter is connected to a supply of a saline mixture by which the balloon 12 in the dilatation catheter is inflated.
In operation, the guide catheter is connect¬ ed to the Y connector and the manifold with its attachments are attached to the Y connector. The guide catheter is inserted via the patient's arm or leg into the patient's coronary artery. As it is snaked through that tortuous path, the rotator 16 permits it to twist while the Y connector and its attachments remain in a relatively fixed position.
With the guide catheter in place, the contrast medium is inserted through the port 30 and the branch passageway 23. With the contrast medium in the coronary artery, an arteriogram shows the cardi¬ ologist the area of blockage.
The dilatation catheter is then inserted into the coronary artery with the balloon 12 posi¬ tioned within the area of blockage. Possibly prelimi¬ nary to the insertion of the dilatation catheter, a small guide wire will have to be inserted in order to open the blocked artery sufficiently to permit the introduction of the balloon catheter. As the dilata¬ tion catheter passes through the membrane 55, it is sealed with respect to the membrane and blood is prevented from exiting the Y connector via the membrane. Blood is also prevented from flowing between the spigot and socket surfaces by the slight compression of the O-ring 40 against the seat 38 and the frustoconical surface 45 on the spigot. As long as collar 61 has not moved outwardly past the collar 60, the seal against flow-by at the rubber seal 40 will remain intact.
Once the dilatation catheter is in place, it is gradually inflated to rupture the placque that is creating the blockage of the coronary artery. The catheter is thereafter withdrawn. When it is with¬ drawn, blood will want to exit through the membrane 50. However, by turning down the spigot onto the Tuohy Borst valve, the valve can be completely closed down, thereby blocking flow of blood out of the main passage 22.
With the catheter removed, contrast medium is again injected and an arteriogram is viewed to determine the success of the procedure thus far. It may be determined that a larger dilata¬ tion catheter should be inserted. If so, that opera¬ tion is performed by partially inserting the catheter up to the Tuohy Borst valve, opening the Tuohy Borst valve and proceeding with the insertion of the cathe- ter. The inflation procedure is repeated.
If it is desired to use a catheter or wire smaller than the .040" to .035" diameter bore in the membrane 55, the leakage can be blocked by the turning down of the Tuohy Borst valve, care being exercised to prevent the crushing of the small catheter or impart¬ ing such a great friction to it or the wire that it cannot be threaded into the artery.
From the above disclosure of the general principles of the present invention and the preceding detailed description of a preferred embodiment, those skilled in the art will readily comprehend the various modifications to which the present invention is susceptible. Therefore, we desire to be limited only by the scope of the following claims and equivalents thereof:

Claims

What is claimed is:
1. A Y-connector for an angioplasty procedure comprising, a casing having a bore forming a main passageway for a catheter and having a branch passage¬ way intersecting the main passageway, a Tuohy-Borst valve in the main passageway, and a membrane disposed in said main passageway, said membrane being coaxial with and spaced from said Tuohy-Borst valve, said membrane having a small hole for receiving a dilatation catheter.
2. A Y-connector for an angioplasty procedure comprising, a casing having a bore forming a main passageway for a catheter and having a branch passage¬ way intersecting the main passageway, a first seal in said main passageway having a circular opening therethrough, means for adjusting the diameter of said opening to any diameter between about .050 inch and zero, and a second elastomeric seal in said main passageway having a fixed circular opening having a diameter in the range of about .040 to .035 inch, said second seal preventing blood flow by a dilatation catheter inserted in said passageway, said first seal being adapted to close said passageway when a catheter is removed.
3. A connector as in claim 2 further compris¬ ing, a closure on said passageway at one end of said casing, said second seal being mounted on said closure, said closure being threaded onto said casing, a spigot on said closure projecting into passageway and in contact with said first seal, said spigot being operative to close the opening in said seal when moved toward said seal by rotating said closure.
4. A connector as in claim 3 in which said first seal provides a seal against flow of fluids between the outside of said spigot and said casing.
5. A connector as in claim 4 further compris- ing, detent means limiting axial movement of said closure and spigot away from said first seal whereby to maintain pressure of said spigot on said first seal.
6. A Y-connector for an angioplasty procedure comprising, a casing having a bore forming a main passageway for a catheter and having a branch passage- way intersecting said main passageway, a shoulder forming a seat in said main passageway, a compressible O-ring on said seat, a closure at one end of said passageway and threaded on said casing, a spigot on said closure extending into said passageway to compress said O-ring against said seat and to prevent fluid flow between the outside of said spigot and said casing, said spigot adapted, upon screwing down said closure, to close said O-ring, a membrane in said closure spaced from and axially aligned with said O-ring, said membrane having a circular opening about .040 inch in diameter to receive and seal a catheter, and detent means between said spigot and passageway to restrict movement of said spigot away from said O-ring and thus to maintain said O-ring always under some compression.
PCT/US1988/003411 1988-02-01 1988-10-03 Y connector for angioplasty procedure WO1989006986A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
DK069090A DK69090D0 (en) 1988-02-01 1990-03-16 Connector piece with Y-shape for use in angioplasty

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US150,778 1988-02-01
US07/150,778 US4886507A (en) 1988-02-01 1988-02-01 Y connector for angioplasty procedure

Publications (1)

Publication Number Publication Date
WO1989006986A1 true WO1989006986A1 (en) 1989-08-10

Family

ID=22535953

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1988/003411 WO1989006986A1 (en) 1988-02-01 1988-10-03 Y connector for angioplasty procedure

Country Status (6)

Country Link
US (1) US4886507A (en)
EP (1) EP0366733A1 (en)
CA (1) CA1293666C (en)
DK (1) DK69090D0 (en)
ES (1) ES2012256A6 (en)
WO (1) WO1989006986A1 (en)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0449510A2 (en) * 1990-03-22 1991-10-02 Critikon, Inc. Bloodless catheter with self-shielding needle
US5203774A (en) * 1990-01-30 1993-04-20 C. R. Bard Ireland Limited Device for use with a catheter
WO1994001169A1 (en) * 1992-07-01 1994-01-20 Advanced Cardiovascular Systems, Inc. Sheath to prevent backbleed through a hemostatic valve
US5334160A (en) * 1992-05-04 1994-08-02 Scimed Life Systems, Inc. Intravascular catheter with sleeve and method for use thereof
EP0654282A1 (en) * 1993-11-19 1995-05-24 David D. Dr Henderson Improvement intravenous catheter assembly
WO2023049174A1 (en) * 2021-09-21 2023-03-30 Bard Access Systems, Inc. Introducer adapters and introducer assemblies

Families Citing this family (62)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5304156A (en) * 1988-06-02 1994-04-19 C. R. Bard, Inc. Self-sealing guidewire and catheter introducer
US5088991A (en) * 1988-07-14 1992-02-18 Novoste Corporation Fuseless soft tip angiographic catheter
US5226898A (en) * 1989-08-30 1993-07-13 The Kendall Company Catheter adapter with strain relief
US5125915A (en) * 1990-03-02 1992-06-30 Cardiopulmonics, Inc. Locking y-connector for selective attachment to exterior of medical tubing
US5163922A (en) * 1991-04-29 1992-11-17 Charles E. McElveen, Jr. Dual-valved connector for intravenous systems
US5769812A (en) 1991-07-16 1998-06-23 Heartport, Inc. System for cardiac procedures
US6482171B1 (en) 1991-07-16 2002-11-19 Heartport, Inc. Multi-lumen catheter
US5584803A (en) 1991-07-16 1996-12-17 Heartport, Inc. System for cardiac procedures
US5167636A (en) * 1991-10-24 1992-12-01 Mectra Labs, Inc. Cannula sealing mechanism
US5207647A (en) * 1991-11-05 1993-05-04 Phelps David Y Needle device
US5209740A (en) * 1991-11-22 1993-05-11 Abbott Laboratories Catheter adapter having retention notches
US6224619B1 (en) * 1991-12-17 2001-05-01 Heartport, Inc. Blood vessel occlusion trocar having size and shape varying insertion body
US5624414A (en) * 1992-02-18 1997-04-29 St. Francis Research Institute Needleless straight infusion port
US5464399A (en) * 1992-02-18 1995-11-07 St. Francis Research Institute Needleless intravenous infusion system
US5352215A (en) * 1992-08-26 1994-10-04 Scimed Life Systems, Inc. Y-adapter with a sideport radius
US5549576A (en) * 1993-05-07 1996-08-27 C. R. Bard, Inc. Vascular introducer valve with proximal self-lubrication
US5413561A (en) * 1993-05-13 1995-05-09 Cathco, Inc. Guiding catheter with sealing cap system for reducing blood loss when inserting guiding catheters
US5338308A (en) * 1993-06-30 1994-08-16 Wilk Peter J Method and apparatus for inhibiting catheter sepsis
ES2052459B1 (en) * 1993-07-02 1995-02-01 Biomed S A VARIABLE GEOMETRY OCCLUSING BALL FOR TEMPORARY OR FINAL CLOSURE OF SEPTAL DEFECTS AND OTHER APPLICATIONS.
AU1331595A (en) * 1993-11-30 1995-06-19 Medex, Inc. Anti-reflux valve with environmental barrier
WO1995015195A1 (en) * 1993-11-30 1995-06-08 Medex, Inc. Plastic needleless valve housing for standard male luer locks
US5403284A (en) * 1994-01-27 1995-04-04 The Kendall Company Automatic lumen shut-off
US5478331A (en) * 1994-05-11 1995-12-26 Localmed, Inc. Multi-function proximal end adapter for catheter
US5478309A (en) 1994-05-27 1995-12-26 William P. Sweezer, Jr. Catheter system and method for providing cardiopulmonary bypass pump support during heart surgery
US5613954A (en) * 1994-11-21 1997-03-25 Stryker Corporation Laparoscopic surgical Y-tube cannula
JP3795591B2 (en) * 1996-09-19 2006-07-12 テルモ株式会社 Catheter connector
US5895376A (en) 1996-10-23 1999-04-20 Mayo Foundation For Medical Education And Research Hemostasis valve, system and assembly
US5807330A (en) * 1996-12-16 1998-09-15 University Of Southern California Angioplasty catheter
US5755687A (en) 1997-04-01 1998-05-26 Heartport, Inc. Methods and devices for occluding a patient's ascending aorta
US6090096A (en) 1997-04-23 2000-07-18 Heartport, Inc. Antegrade cardioplegia catheter and method
US5957898A (en) 1997-05-20 1999-09-28 Baxter International Inc. Needleless connector
US6261282B1 (en) 1997-05-20 2001-07-17 Baxter International Inc. Needleless connector
US6159178A (en) 1998-01-23 2000-12-12 Heartport, Inc. Methods and devices for occluding the ascending aorta and maintaining circulation of oxygenated blood in the patient when the patient's heart is arrested
US6331176B1 (en) 1999-03-11 2001-12-18 Advanced Cardiovascular Systems, Inc. Bleed back control assembly and method
US6254061B1 (en) * 1999-04-30 2001-07-03 Scimed Life Systems, Inc. Medical suction valve
US6613014B1 (en) * 2000-06-09 2003-09-02 Advanced Cardiovascular Systems, Inc. Catheter hub with detachable push device
US6908459B2 (en) 2001-12-07 2005-06-21 Becton, Dickinson And Company Needleless luer access connector
US6834842B2 (en) * 2002-01-09 2004-12-28 Scimed Life Systems, Inc. Fluid management valve
US8137317B2 (en) * 2002-03-15 2012-03-20 Oscor Inc. Locking vascular introducer assembly with adjustable hemostatic seal
US6712798B2 (en) * 2002-03-18 2004-03-30 Corazon Technologies, Inc. Multilumen catheters and methods for their use
US20040172008A1 (en) * 2002-11-19 2004-09-02 Gmp/Cardiac Care, Inc. Hemostasis valve and method of using a hemostasis valve
US7582070B2 (en) * 2004-04-09 2009-09-01 Cook Vascular Incorporated Modular hemostatic valve
US7914519B2 (en) * 2005-06-23 2011-03-29 Elcam Medical Agricultural Cooperative Association, Ltd. Catheter device
US7621946B2 (en) * 2006-03-06 2009-11-24 Boston Scientific Scimed, Inc. Implantable medical endoprosthesis delivery system with hub
CA2677343C (en) 2007-02-05 2016-06-21 Boston Scientific Limited Thrombectomy apparatus and method
US9011412B2 (en) * 2008-05-16 2015-04-21 Ford Albritton, IV Apparatus, system and method for manipulating a surgical catheter and working device with a single hand
US7717900B2 (en) * 2008-05-28 2010-05-18 Angio Dynamics, Inc. Locking clamp
US20100036329A1 (en) * 2008-08-07 2010-02-11 Nasser Razack Hemostasis valve
US9510854B2 (en) 2008-10-13 2016-12-06 Boston Scientific Scimed, Inc. Thrombectomy catheter with control box having pressure/vacuum valve for synchronous aspiration and fluid irrigation
US20110112375A1 (en) * 2009-11-12 2011-05-12 Tyco Healthcare Group Lp Portal apparatus including conformable cup seal
CN103237571A (en) * 2011-02-25 2013-08-07 泰尔茂株式会社 Medical connector
US9005266B2 (en) 2011-10-10 2015-04-14 Robert Feldtman Vascular delivery methods
EP2793722A1 (en) 2011-12-22 2014-10-29 DePuy Synthes Products, LLC Length-adjustable vertebral body balloon
EP2931131B1 (en) * 2012-12-13 2022-11-09 Philips Image Guided Therapy Corporation Rotational catheter with extended catheter body drive shaft support
US9675792B2 (en) 2013-08-05 2017-06-13 Cook Medical Technologies Llc Hemostasis mechanism and method
US9883877B2 (en) 2014-05-19 2018-02-06 Walk Vascular, Llc Systems and methods for removal of blood and thrombotic material
US10561440B2 (en) 2015-09-03 2020-02-18 Vesatek, Llc Systems and methods for manipulating medical devices
WO2017075528A1 (en) 2015-10-30 2017-05-04 ECMOtek, LLC Devices for endovascular access through extracorporeal life support circuits
US10492805B2 (en) 2016-04-06 2019-12-03 Walk Vascular, Llc Systems and methods for thrombolysis and delivery of an agent
US10716880B2 (en) 2018-06-15 2020-07-21 Incuvate, Llc Systems and methods for aspiration and monitoring
US11678905B2 (en) 2018-07-19 2023-06-20 Walk Vascular, Llc Systems and methods for removal of blood and thrombotic material
US20230270988A1 (en) * 2022-02-25 2023-08-31 Boston Scientific Medical Device Limited Dual arm hemostasis valve hub for introducer sheaths

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4254773A (en) * 1978-11-24 1981-03-10 Medex Inc. Swivel coupling for a catheterization system
US4424833A (en) * 1981-10-02 1984-01-10 C. R. Bard, Inc. Self sealing gasket assembly
US4430081A (en) * 1981-01-06 1984-02-07 Cook, Inc. Hemostasis sheath
US4626245A (en) * 1985-08-30 1986-12-02 Cordis Corporation Hemostatis valve comprising an elastomeric partition having opposed intersecting slits
US4723550A (en) * 1986-11-10 1988-02-09 Cordis Corporation Leakproof hemostasis valve with single valve member
US4726374A (en) * 1985-12-09 1988-02-23 Cordis Corporation Leakproof hemostasis valve

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4311137A (en) * 1980-04-30 1982-01-19 Sherwood Medical Industries Inc. Infusion device
JPS6145774A (en) * 1984-08-07 1986-03-05 テルモ株式会社 Medical instrument
US4769017A (en) * 1985-04-04 1988-09-06 Fath John J Self-sealing infusion manifold and catheter connector
CH671159A5 (en) * 1986-06-20 1989-08-15 Contempo Products

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4254773A (en) * 1978-11-24 1981-03-10 Medex Inc. Swivel coupling for a catheterization system
US4430081A (en) * 1981-01-06 1984-02-07 Cook, Inc. Hemostasis sheath
US4424833A (en) * 1981-10-02 1984-01-10 C. R. Bard, Inc. Self sealing gasket assembly
US4626245A (en) * 1985-08-30 1986-12-02 Cordis Corporation Hemostatis valve comprising an elastomeric partition having opposed intersecting slits
US4726374A (en) * 1985-12-09 1988-02-23 Cordis Corporation Leakproof hemostasis valve
US4723550A (en) * 1986-11-10 1988-02-09 Cordis Corporation Leakproof hemostasis valve with single valve member

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5203774A (en) * 1990-01-30 1993-04-20 C. R. Bard Ireland Limited Device for use with a catheter
EP0449510A2 (en) * 1990-03-22 1991-10-02 Critikon, Inc. Bloodless catheter with self-shielding needle
EP0449510A3 (en) * 1990-03-22 1992-01-02 Critikon, Inc. Bloodless catheter with self-shielding needle
US5334160A (en) * 1992-05-04 1994-08-02 Scimed Life Systems, Inc. Intravascular catheter with sleeve and method for use thereof
WO1994001169A1 (en) * 1992-07-01 1994-01-20 Advanced Cardiovascular Systems, Inc. Sheath to prevent backbleed through a hemostatic valve
EP0654282A1 (en) * 1993-11-19 1995-05-24 David D. Dr Henderson Improvement intravenous catheter assembly
WO2023049174A1 (en) * 2021-09-21 2023-03-30 Bard Access Systems, Inc. Introducer adapters and introducer assemblies

Also Published As

Publication number Publication date
DK69090A (en) 1990-03-16
ES2012256A6 (en) 1990-03-01
EP0366733A1 (en) 1990-05-09
CA1293666C (en) 1991-12-31
US4886507A (en) 1989-12-12
DK69090D0 (en) 1990-03-16

Similar Documents

Publication Publication Date Title
US4886507A (en) Y connector for angioplasty procedure
US4838269A (en) Manifold for angioplasty balloon catheter
US5575767A (en) Method and apparatus for high pressure one-way fluid valving in angiography
US5197952A (en) Auto-inflating catheter cuff
US4857062A (en) Catheter introducer valve
US6221057B1 (en) Hemostasis valve, system and assembly
US7226433B2 (en) Thrombectomy catheter device having a self-sealing hemostasis valve
US5669881A (en) Vascular introducer system incorporating inflatable occlusion balloon
US4730616A (en) Multiple probe angioplasty apparatus and method
EP0906135B1 (en) Low profile catheter valve
EP0900105B1 (en) Hemostasis valve
US4726374A (en) Leakproof hemostasis valve
US5336192A (en) Self-sealing valve device for angiographic catheters
CA2172001C (en) Luer-type connector
US6270489B1 (en) Anti-clotting methods and apparatus for indwelling catheter tubes
US5125903A (en) Hemostasis valve
US4235232A (en) Hub device for preventing liquid leakage
JP3893246B2 (en) Blood backflow control valve
US5395330A (en) Auto-inflating catheter cuff
US7377909B2 (en) Connection assembly for use with splittable sheath
US20070276434A1 (en) Vascular sheath
US7094218B2 (en) Valved catheter
US20020103473A1 (en) Intravascular occlusion balloon catheter
EP1198262A1 (en) Catheter with check valve
EP0607343B1 (en) Rotatable medical valve closure

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): DK

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): AT BE CH DE FR GB IT LU NL SE

WWE Wipo information: entry into national phase

Ref document number: 1989901669

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 1989901669

Country of ref document: EP

WWW Wipo information: withdrawn in national office

Ref document number: 1989901669

Country of ref document: EP